Intensity Therapeutics, Inc.
INTS
$4.04
$0.020.50%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 9.53M | 10.25M | 11.92M | 7.07M | 2.22M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.70M | 661.00K | 788.00K | 1.12M | 822.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 11.23M | 10.91M | 12.71M | 8.19M | 3.04M |
|
|
|||||
| Total Current Assets | 11.23M | 10.91M | 12.71M | 8.19M | 3.04M |
| Net Property, Plant & Equipment | 82.00K | 89.00K | 96.00K | 103.00K | 109.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 210.00K | 1.30M | 1.30M | 1.30M | 1.30M |
| Total Assets | 11.52M | 12.29M | 14.10M | 9.59M | 4.44M |
|
|
|||||
| Total Accounts Payable | 1.01M | 636.00K | 583.00K | 1.68M | 1.19M |
| Total Accrued Expenses | 1.20M | 1.57M | 1.53M | 561.00K | 941.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 33.00K | 32.00K | 31.00K | 31.00K | 30.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.25M | 2.24M | 2.15M | 2.28M | 2.16M |
|
|
|||||
| Total Current Liabilities | 2.25M | 2.24M | 2.15M | 2.28M | 2.16M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 62.00K | 70.00K | 79.00K | 87.00K | 95.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.31M | 2.31M | 2.23M | 2.36M | 2.26M |
|
|
|||||
| Common Stock & APIC | 93.04M | 90.80M | 90.27M | 82.56M | 74.85M |
| Retained Earnings | -83.83M | -80.82M | -78.39M | -75.34M | -72.67M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 9.21M | 9.98M | 11.88M | 7.22M | 2.18M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 9.21M | 9.98M | 11.88M | 7.22M | 2.18M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.21M | 9.98M | 11.88M | 7.22M | 2.18M |
|
|
|||||